InterMob: a Randomized Controlled Trial Aimed at Reducing Car Use in Regular Car Users
Launched by AINA CHALABAEV · Oct 14, 2021
Trial Information
Current as of July 01, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Sample size : The investigators have calculated the sample size considering :
* the proportion of trips made by car (49% of the trips made in Grenoble Metropole are made by car according to the EMD, 2010 which is the most recent survey in the area currently available),
* the potential target population's transport behavior (a percentage of the population can be classified as reluctant drivers with positive attitudes toward other modes of transportation, this population makes 80% of their trips and could potentially reduce their car use to 64% considering the characteristics of the trips)
*...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being at least 18 years old at the time of inclusion
- • • Profile: employed / unemployed / retired / on work-study or apprenticeship
- • If employed : Work and live in the SMAAG territory (Metropole of Grenoble + Grésivaudan + Pays voironnais)
- • If in apprenticeship/training program: Working, studying and living in the SMAAG territory (Metropole of Grenoble + Grésivaudan + Pays voironnais)
- • If unemployed / retired : Reside in the SMAAG territory (Metropole of Grenoble + Grésivaudan + Pays voironnais)
- • The car/motorcycle/scooter is the main mode of travel during the week (excluding weekends)
- • Travels 3, 4, or 5 days by car (excluding weekdays)
- • Thinks about reducing car use or has started to reduce car use - Expect to live and work in the Grenoble area in the next 2 years (Very likely and likely options)
- Exclusion Criteria:
- • Being a student
- • Living outside the Metropole of Grenoble + Grésivaudan + Pays voironnais
- • Working outside (Metropole of Grenoble + Grésivaudan + Pays voironnais)
- • Studying outside (Metropole of Grenoble + Grésivaudan + Pays voironnais)
- • Car/motorcycle/scooter is not the main mode of travel
- • Travels 0, 1 or 2 days a week by car
- • Does not intend to reduce the frequency of car use
- • Does not expect to live and/or work in the Grenoble area in the next 2 years
About Aina Chalabaev
Aina Chalabaev is a dedicated clinical trial sponsor committed to advancing medical research through innovative study designs and rigorous methodologies. With a focus on enhancing patient outcomes, the organization leverages expert knowledge in various therapeutic areas to facilitate the development of new treatments. Aina Chalabaev emphasizes collaboration with healthcare professionals, regulatory bodies, and academic institutions to ensure the highest standards of ethical conduct and scientific integrity in clinical trials. Through its strategic approach, the sponsor aims to contribute significantly to the healthcare landscape by bringing groundbreaking therapies to market efficiently and effectively.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saint Martin D'hères, Rhône Alpes, France
Saint Martin D'hères, , France
Patients applied
Trial Officials
Aïna Chalabaev, Professor
Study Director
Laboratoire SENS, Univ. Grenoble-Alpes
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials